SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form CORRESP - Correspondence:
SEC Accession No. 0001104659-21-130909
Filing Date
2021-10-28
Accepted
2021-10-28 13:48:36
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 7060
  Complete submission text file 0001104659-21-130909.txt   8050
Mailing Address 414 COMMERCE DRIVE STE 120 FORT WASHINGTON PA 19034
Business Address 25-28 NORTH WALL QUAY DUBLIN L2 D01 H104 (610) 816-6640
Nabriva Therapeutics plc (Filer) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations